Details Basic Details Date Wednesday, September 23, 2020 Type Presentation Materials Utilization of Spironolactone in Patients with Reduced or Preserved Ejection Fraction Heart Failure Additional Information Information Host 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management ICPE All Access Conference Abstracts Sentinel Drug Study: Aldactone (spironolactone) & Indications for Use Sentinel Drug Analysis: Spironolactone Use in Patients with Reduced Ejection Fraction Heart Failure (HFrEF) or Preserved Ejection Fraction Heart Failure (HFpEF) Contributors Presenter(s) Sruthi Adimadhyam, Austin Cosgrove, Qoua Her, Jennifer G. Lyons, Dave Martin, Efe Eworuke